Pharmaceutical and Life Sciences

Venture Capital funding in the life sciences industry for Q1 2013

Transactions should trend at an active pace during 2013 as pharmaceutical and biotechnology companies seek acquisitions in select asset classes and medical device and diagnostics companies evaluate new growth strategies.

The ratings culture in the US has exploded in the last decade with consumers turning to reviews for dining, shopping, vacationing, and even home improvements. Now, as they spend more of their own money on health and wellness, consumers are beginning to search for rating systems to guide their decision making.

The healthcare industry is projected to experience a shortage in qualified information technology (IT) talent at a time when Health IT, or HIT, is increasingly critical to meeting business needs, consumer expectations, and regulatory requirements while capitalizing on new growth prospects.

Biopharmaceutical companies are expanding into emerging markets, sometimes without involving supply chain operations. The operational function (operations) should play a strategic role in emerging market expansion planning.